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The overwhelming fraction of proteins whose sequences have been collected in comprehensive databases may never
be assessed for function experimentally. Commonly, putative function is assigned based on similarity to experimentally
characterized homologs, either on the level of the entire protein or for single evolutionarily conserved domains.
The annotation of individual sites provides more detailed insights regarding the correspondence between sequence and
function, as well as context for the interpretation of sequence variation and the outcomes of experiments. In general, site
annotation has to be extracted from the published literature, and can often be transferred to closely related sequence
neighbors. The National Center for Biotechnology Information’s Conserved Domain Database (CDD) provides a system for
curators to record functional (such as active sites or binding sites for cofactors) or characteristic sites (such as signature
motifs), which are conserved across domain families, and for the transfer of that annotation to protein database sequences
via high-confidence domain matches. Recently, CDD curators have begun to sort-site annotations into seven categories
(active, polypeptide binding, nucleic acid binding, ion binding, chemical binding, post-translational modification and other)
and here we present a first comparative analysis of sites obtained via domain model matches, juxtaposed with existing site
annotation encountered in high-quality data sets. Site annotation derived from domain annotation has the potential to
cover large fractions of protein sequences, and we observe that CDD-based site annotation complements existing site
annotation in many cases, which may, in part, originate from CDD’s curation practice of collecting sites conserved across
diverse taxa and supported by evidence from multiple 3D structures.
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Introduction
The Conserved Domain Database (CDD) (1) is a manually
curated protein annotation resource developed and
maintained by the National Center for Biotechnology
Information (NCBI). CDD collects a large set of protein
and protein domain models, as multiple sequence align-
ments and derived position-specific score matrices
(PSSMs), and uses RPS-BLAST (2), a variant of the widely
used PSI-BLAST algorithm (3), to match protein database
sequences with these family models. While the majority
of models are imported from external sources, the CDD
curation team is revisiting larger protein domain superfa-
milies to establish finer-grained hierarchical classifications
that are based on phylogenetic analysis and supported by
the published literature, functional annotation, domain
architecture and taxonomic distribution. While charac-
terizing individual subfamilies, curators also record con-
served functional sites and evidence for those sites, in a
way so that sites can be mapped onto protein sequences
using pre-computed protein-model alignments as collected
in the Conserved Domain Architecture Retrieval Tool
(CDART) database (4). CDD-based site annotation is readily
visible on Entrez’s GenPept summary pages for proteins
and in graphical views (Figure 1), and it is being distributed
via NCBI’s Reference Sequence protein data sets (5). More
recently, CDD site annotation is used to verify and rank
clusters of interactions observed in 3D structures as pre-
sented by the Inferred Biomolecular Interactions Server
(IBIS) resource (6), where such clusters can be used to
infer interactions for proteins sequence similar to those
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in the domain mapping of disease mutations (DMDMs) re-
source, where it can be contrasted with known disease mu-
tations and polymorphisms (7).
SwissProt, as maintained by the UniProt Knowledgebase
(8), is a resource that provides high-quality manually
curated annotation of protein sequences. SwissProt-anno-
tated sequences are tracked by NCBI’s Entrez protein data-
base, including the site annotation provided by the source
data. Here, we present a study that examines a subset of
the SwissProt-based sequences tracked by Entrez, namely
those already covered by NCBI-curated domain models,
and compares site annotations that originate from CDD
with annotation originating from SwissProt.
Conserved domain site annotation
The curation of domain models in CDD aims at characteriz-
ing protein domain superfamilies as collections of sequence
fragments related by common evolutionary descent, orga-
nized into multiple sequence alignments and split into
subfamilies that reflect ancient gene duplication events
and subsequent divergent evolution. Curation of CDD-con-
served domain hierarchies has been explained in previous
manuscripts (9). Typically, a domain subfamily is created
and annotated if it is supported by phylogenetic analysis
and contains member sequences from diverse organisms,
suggesting an origin several hundred million years in the
past. To this end, curators compute and examine sequence
tree displays, to select robust branches and will consider
taxonomic distribution, domain architecture, protein anno-
tation and existing/external classifications. CDD curators
make extensive use of protein 3D structure, when available,
as in-house curation tools are tightly coupled to the Entrez
3D structure database Molecular Modeling Database
(MMDB) (10) and structure neighboring data computed
with Vector Alignment Search Tool (VAST) (11), and the
associated 3D viewer Cn3D (12) is the main alignment view-
ing and editing tool. From examining patterns of sequence
conservation, the published literature, and the 3D struc-
tures of complexes that may contain proteins interacting
with binding partners, curators often notice and record
the location of functional sites or motifs characteristic for
a domain family. Sites are recorded as addresses on the
multiple sequence alignment models that describe the
domain family, and this mapping is being transferred into
the coordinates of the PSSMs that are used to scan the
protein sequence database. From an alignment of a protein
sequence to a PSSM, the site coordinates can be again
transferred onto the protein sequence itself. This is only
done if the mapping of the site is near complete; partially
aligned sites are not used to infer sites on protein se-
quences. Functional sites associated with a domain model
Figure 1. Entrez Protein graphical sequence view for SwissProt sequence P28845.3, gij118569. At the bottom of the view, site
annotation (labeled ‘site Features’) from CDD and as encountered in the original record are visible on top of each other. Note
that CDD annotates the homodimerization interface, substrate and cofactor binding sites and active site as relatively large sets of
disjoint residue positions. The homodimer interface annotation is not present in the original annotation, but it provides unique
labeling of glycosylation sites.
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hits to that model. Sites are recorded with a short name,
such as ‘active site’ or ‘ATP binding site’. Although common
site names are now being selected from a list of
pre-defined expressions, the name is stored as free text
and can be modified by the curators as they see fit. We
have recently started to assign site types and to retrofit
existing models with site-type definitions. CDD deliberately
picked a small number of seven generic site types, so that
the majority of annotations that we will come across can be
sorted into the seven types in a straightforward manner.
The site types were also selected to match the IBIS classifi-
cation of interaction sites (6), as CDD curators use IBIS in the
curation work flow. Curators pick common site names from
a small set of pre-defined and generic options (such as
‘active site’ or ‘dimerization interface’), but also refer to
the literature when deciding on a site name, and are free
to choose very specific names if deemed appropriate. The
site types used in CDD are listed in Table 1.
Curators also record evidence together with the con-
served site annotation, which is presented to CDD users
via conserved domain summary pages. Evidence may be
free text comments, references to journal articles or struc-
ture evidence, which contains instructions for highlighting
a site in a particular 3D structure used in the model, to-
gether with a binding partner that exemplifies the biologic-
al significance of the site annotation.
Conserved sites are annotated only if it seems reasonable
to assume that the site is present in all or nearly all se-
quence fragments specifically annotated by the respective
model. Mapping of sites via homologous relationship will
undoubtedly generate false annotation, but that fraction is
expected to be small if (1) site annotation is restricted to
well-conserved motifs that are linked to the generic func-
tion of the domain family, and (2) a conservative procedure
is used to qualify a match for mapping sites. Consequently,
site annotation in CDD is restricted to sites that tend to be
well conserved in divergent evolution. It is evident from
Table 1 that relatively few post-translational modification
(PTM) sites have been recorded, for example, as these tend
to evolve rather quickly and are often not associated with
the structurally conserved core segments of conserved do-
mains, which constitute the bulk of CDD’s alignment
models. The low number of PTM sites is most likely due
to the lack of conservation between sites in a single
domain model; their annotation would require further
fine-grained subfamily classification, as curators only anno-
tate sites that appear conserved in all or nearly all repre-
sentative sequences of a domain model.
Specific domain hits and site mapping
The collection of domain models in CDD is redundant, as
CDD mirrors several external resources. It is quite common
to have the same domain family described by models from
three or four different sources, and if hierarchical classifi-
cations of diverse superfamilies are available, dozens of
models may provide overlapping annotation for a particu-
lar region on a protein. To deal with this redundancy, CDD
presents a simplified default view of domain search results:
models describing homologous families are grouped to-
gether into superfamily clusters, and the annotation with
a superfamily cluster is presented instead of the single
model that happened to score the best hit. However, if
the highest ranked hit was scored by an NCBI-curated
model, and that score exceeds a model-specific threshold,
(13) the ‘specific hit’ is presented on top of the superfamily
annotation. CDD follows simple rules for mapping site
annotations onto protein sequences: functional sites
associated with a domain model are only mapped onto
proteins with high scoring-specific hits to that model.
If only a superfamily annotation is shown, but if the set
of redundant hits includes an NCBI-curated model, site an-
notation is mapped from the root node of the conserved
domain hierarchy that model came from—annotating only
the most generic sites that are presumed conserved across
the entire superfamily.
Methods
A subset of NCBI’s Entrez protein sequence records contain
site annotation provided by the originating source data-
base. For the analysis presented here, we chose to use se-
quences that are flagged as originating from SwissProt.
Sixty-six percent of all SwissProt sequences in Entrez/
Table 1. Site types and names as defined in Conserved




Examples of common names Counts
Active Active site, catalytic site 3300
Polypeptide
binding
Dimer interface, oligomer interface 3020
Nucleic acid
binding
DNA binding site, RNA binding site 482
Ion binding Ca binding site, Zn binding site 1500
Chemical
binding
ATP binding site, NAD(P) binding site 3310
PTM Glycosylation site, phosphorylation site 104
Other Walker A/P-loop, activation loop 4439
a
The counts reflect the numbers of site annotations recorded on
CDD models in the most recent release, v2.32.
aNote that sites without any explicit alternative type assignment
are flagged ‘other’; as site typing is an ongoing process, this
number reflects models that still need to be revisited more than
the actual fraction of sites that cannot be sorted into a more
specific category.
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of these had hits to specific CDD-curated domain models;
 45% of all SwissProt records had such specific hits. We
focused the analysis on the latter, SwissProt sequences
that had specific domain annotation from CDD, meaning
that at least one sequence region comes with high-
confidence identification of a conserved domain, which
may also include mapped site annotation. This restricts
the analysis to a set of protein domain families that have
undergone curation by CDD staff to date, and it results in
233,722 sequences (as of September 2011). Site annotations
in those sequences were collected, including the site
type assigned in each case. Pre-existing (non-CDD) site an-
notation, which was interpreted as stemming from the
SwissProt curation effort, is categorized into a larger set
of 12 site types in Entrez, which reflects the site typing
undertaken by curatorial staff at the source database,
while CDD-based site annotation uses the 7 types outlined
in Table 1. We defined two sites from different sources as
overlapping if they shared one or more residue coordinate
on the protein sequence. In the analysis presented below,
we did not try to map site types between CDD and Entrez/
protein.
Results and conclusions
CDD maps site annotation onto several million proteins in
Entrez. Figure 2 presents the site annotation coverage for
the subset analyzed in this manuscript.
It seems evident that CDD site annotations contribute
to a large fraction of the proteins that are covered by
the current curation effort. Of the 1491437 individual
site annotations we tracked, just a little more than half
(53.3%) came from mapping of CDD sites, and they are
spread across 97% of the sequences in the set, reflecting
the fact that the majority of NCBI-curated domain models
do also come with functional site annotation. In more than
Figure 2. The 233722 protein sequences we analyzed can be categorized based on the source of site annotation. A small
number, 1.32% of the SwissProt sequences with specific hits to NCBI-curated domain models, do not have any site annotation.
The 1.62% have site annotation only from SwissProt, and 11.16% have CDD site annotation that appears redundant (overlaps
with existing SwissProt annotation). For the remaining 85.9%, CDD provides some unique site annotation, and for about
one-third of the sequences CDD provides the only site annotation.
Figure 3. The 794228 site annotations on protein sequences
we analyzed, which were generated via mapping to CDD
models, can be categorized based on the site type assigned
by CDD. A large fraction of sites is assigned type ‘0’ or ‘other’,
as the typing of all previously recorded sites has not been
completed. These are not shown here. CDD annotates only a
small number of PTM sites, as these are rarely conserved
across somewhat diverse domain families. The bars are col-
ored according to the overlap with SwissProt sites (irrespective
of the SwissProt site type). It appears that polypeptide-binding
sites, those conferring protein–protein interactions, are most
often uniquely annotated by CDD.
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overlaps with annotation provided by SwissProt, but CDD
also contributes unique sites, and sometimes the only site
annotation available at this point. Figures 3 and 4 detail the
distributions of site annotations according to the assigned
site type, for CDD and SwissProt, accordingly.
While there is a large degree of overlap between
CDD-generated site annotation and SwissProt-generated
annotation, we notice that the two data sources also com-
plement each other to a certain degree; for  33% of the
SwissProt sequences with specific CDD domain annotation,
CDD provides the only site annotation. Individual sequence
curation—and inference of sites between close homologs—
can record the presence of functional sites that are not
conserved across more diverse families. The comparative
analysis of protein 3D structure complexes, on the other
hand, enables CDD curators to record the positions of inter-
faces with which macromolecules interact, including homo
and hetero-oligomerization interfaces. It may be helpful to
consider both sources of annotation in the study of protein
function and the design of experiments, so as to benefit
from curation work approaching the issue from different
angles.
The strength of CDD’s approach is that conserved sites
can be annotated on large numbers of protein sequences
with relatively little effort, as a single model may provide
‘specific domain hits’ to hundreds or thousands of protein
sequences. Naturally, this will also lead to a higher inci-
dence of false positive annotation. We are in the process
of implementing curation software that allows for condi-
tional functional sites: curators will be able to specify the
amino acid residue types that are allowed in selected pos-
itions of a functional site. Consequently, sites will be only
mapped onto sequences if the site address matches such a
defined sequence motif that is associated with known or
proven function. While this is expected to reduce the inci-
dences of false annotation, it will be particularly useful for
annotating sites that are known as not strictly conserved
across all sequences that define a domain family, such as
PTM sites.
Feedback with respect to inaccurate site annotation
or supporting and conflicting experimental evidence is
welcome and concerns can be addressed efficiently via
the CDD curation pipeline.
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